Patents Assigned to Sloan-Kettering Inststute for Cancer Research and The Animal Medical Center
  • Compositions for treatment of melanoma and method of using same
    Patent number: 7556805
    Abstract: Melanoma can be treated in a mammalian subject by administering to the subject an immunologically-effective amount of a xenogeneic melanoma-associated differentiation antigen. For example, genetic immunization with a plasmid containing a sequence encoding human gp75 has been shown to be effective in treatment of dogs with melanoma.
    Type: Grant
    Filed: November 27, 2001
    Date of Patent: July 7, 2009
    Assignee: Sloan-Kettering Inststute for Cancer Research and The Animal Medical Center
    Inventors: Alan N. Houghton, Philip J. Bergman, Jedd D. Wolchok